| The burden of cardiovascular disease in Asia from 2025 to 2050: a forecast analysis for East Asia, South Asia, South-East Asia, Central Asia, and high-income Asia Pacific regions RSJ Goh, B Chong, J Jayabaskaran, SM Jauhari, SP Chan, MTW Kueh, ... The Lancet Regional Health–Western Pacific 49, 2024 | | 2024 |
| Deep Learning-Based Novel Coronary Artery Calcium Dispersion And Density (CAC-DAD) Score For Predicting Myocardial Infarction And Cardiovascular Death G Huangfu, G Dwivedi, A Ihdayhid, S Kwok, J Konstantopoulos, K Niu, ... Journal of Cardiovascular Computed Tomography 18 (4), S12-S13, 2024 | | 2024 |
| Unlocking Precision: Enhanced MACE Prediction With A Fully Automated Multi-modal System On Computed Tomography Coronary Angiography J Lu, G Dwivedi, A Ihdayhid, M Bennamoun, J Konstantopoulos, S Kwok, ... Journal of Cardiovascular Computed Tomography 18 (4), S8-S9, 2024 | | 2024 |
| Data-driven collaborative QUality improvement in Cardiac Rehabilitation (QUICR) to increase program completion: protocol for a cluster randomized controlled trial D Candelaria, J Redfern, A O’Neil, D Brieger, RA Clark, T Briffa, ... BMC Cardiovascular Disorders 24 (1), 302, 2024 | | 2024 |
| Left ventricular function, congestion, and effect of empagliflozin on heart failure risk after myocardial infarction JA Udell, MC Petrie, WS Jones, SD Anker, J Harrington, M Mattheus, ... Journal of the American College of Cardiology 83 (23), 2233-2246, 2024 | 4 | 2024 |
| Improving clinical outcomes for patients with coronary artery disease despite no standard modifiable cardiovascular risk factors (SMuRF): not out of the woods yet GA Figtree, MP Gray European Heart Journal, ehae271, 2024 | 1 | 2024 |
| Correlation of Noninvasive Cardiac MRI Measures of Left Ventricular Myocardial Function and Invasive Pressure-Volume Parameters in a Porcine Ischemia-Reperfusion Model T Deshmukh, D Selvakumar, S Thavapalachandran, O Archer, GA Figtree, ... Radiology: Cardiothoracic Imaging 6 (3), e230252, 2024 | | 2024 |
| Health economic analysis of polygenic risk score use in primary prevention of coronary artery disease–A system dynamics model ST Vernon, S Brentnall, DJ Currie, C Peng, MP Gray, G Botta, D Mujwara, ... American Journal of Preventive Cardiology 18, 100672, 2024 | | 2024 |
| Inflammatory risk and cardiovascular events in patients without obstructive coronary artery disease: the ORFAN multicentre, longitudinal cohort study K Chan, E Wahome, A Tsiachristas, AS Antonopoulos, P Patel, ... The Lancet, 2024 | 3 | 2024 |
| The prognostic value of metabolic dysfunction‐associated steatotic liver disease in acute myocardial infarction: A propensity score‐matched analysis G Kong, G Cao, J Koh, SP Chan, A Zhang, E Wong, B Chong, SM Jauhari, ... Diabetes, Obesity and Metabolism, 2024 | | 2024 |
| Atherosclerosis evaluation and cardiovascular risk estimation using coronary computed tomography angiography NS Nurmohamed, AR van Rosendael, I Danad, Q Ngo-Metzger, PR Taub, ... European heart journal 45 (20), 1783-1800, 2024 | 2 | 2024 |
| Effect of empagliflozin on heart failure outcomes after acute myocardial infarction: insights from the EMPACT-MI trial AF Hernandez, JA Udell, WS Jones, SD Anker, MC Petrie, J Harrington, ... Circulation 149 (21), 1627-1638, 2024 | 11 | 2024 |
| Participants’ views of ultra-low dose combination therapy for high blood pressure: a mixed-methods study from the QUARTET trial JG Kovoor, CK Chow, A Salam, R Webster, L Shiel, MR Nelson, ... Journal of Human Hypertension, 1-7, 2024 | | 2024 |
| Would healing methods G Figtree, K Bubb, B Di Bartolo US Patent App. 18/278,168, 2024 | | 2024 |
| Genetic testing in cardiovascular disease MP Gray, D Fatkin, J Ingles, EN Robertson, GA Figtree Medical Journal of Australia 220 (8), 428-434, 2024 | 2 | 2024 |
| Therapeutic Inertia With Initial Low-Dose Quadruple Combination Therapy for Hypertension: Results From the QUARTET Trial N Wang, A Von Huben, S Marschner, MR Nelson, JM Nolde, MP Schlaich, ... Hypertension 81 (5), 1087-1094, 2024 | | 2024 |
| Predicting multifaceted risks using machine learning in atrial fibrillation: insights from GLORIA-AF study J Lu, A Bisson, M Bennamoun, Y Zheng, FM Sanfilippo, J Hung, T Briffa, ... European Heart Journal-Digital Health 5 (3), 235-246, 2024 | | 2024 |
| Integrating Cardio-Oncology Across the Research Pipeline, Policy, and Practice in Australia—An Australian Cardiovascular Alliance Perspective AC Singleton, J Redfern, A Diaz, B Koczwara, SJ Nicholls, K Negishi, ... Heart, Lung and Circulation 33 (5), 564-575, 2024 | 5 | 2024 |
| Empagliflozin after acute myocardial infarction J Butler, WS Jones, JA Udell, SD Anker, MC Petrie, J Harrington, ... N Engl J Med 390 (16), 1455-1466, 2024 | 31 | 2024 |
| THE GLOBAL BURDEN OF CARDIOVASCULAR DISEASES OVER THE NEXT 30 YEARS: PREDICTIONS FROM THE PAST 30 YEARS B Chong, J Jayabaskaran, MTW Kueh, RSJ Goh, H Li, YH Chin, G Kong, ... Journal of the American College of Cardiology 83 (13_Supplement), 1996-1996, 2024 | | 2024 |
Stuart GrieveThe University of Sydney在 sydney.edu.au 的电子邮件经过验证
